B
BIVV

Bailard’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bailard’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,009
Closed -$216K – 526
2017
Q4 		$216K Buy
+4,009
New +$219K 0.01% 416

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Bailard's BIVV Position: Q1 2018 in Review

Bailard sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,009 shares — an estimated $216K sold.

Bailard first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $216K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Bailard reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Bailard sold 4,009 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $216K.
  • Bailard first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Bailard's Bioverativ Inc. Common Stock position peaked at $216K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Bailard's 13F filing for Q1 2018, filed 7 May 2018.